Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Human tumor-specific T lymphocytes: does function matter more than number?

Coulie PG, Connerotte T.

Curr Opin Immunol. 2005 Jun;17(3):320-5. Review.

PMID:
15886124
2.

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination.

Romero P, Cerottini JC, Speiser DE.

Cancer Immunol Immunother. 2004 Mar;53(3):249-55. Epub 2003 Dec 24. Review.

PMID:
14704832
3.

Keeping the immune system alerted against cancer.

Paglia P, Guzman CA.

Cancer Immunol Immunother. 1998 Apr;46(2):88-92. Review. No abstract available.

PMID:
9558004
4.

Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer.

Yasumoto K, Hanagiri T, Takenoyama M.

Gen Thorac Cardiovasc Surg. 2009 Sep;57(9):449-57. doi: 10.1007/s11748-008-0433-6. Epub 2009 Sep 13. Review.

PMID:
19756930
5.

Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens.

Pavlenko M, Leder C, Pisa P.

Expert Rev Vaccines. 2005 Jun;4(3):315-27. Review.

PMID:
16026247
6.

Current state of vaccine therapies in non-small-cell lung cancer.

Romero P.

Clin Lung Cancer. 2008 Feb;9 Suppl 1:S28-36. Review.

PMID:
18540532
7.

On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.

Yannelli JR, Wroblewski JM.

Vaccine. 2004 Nov 15;23(1):97-113. Review.

PMID:
15519713
8.

Current developments with peptide-based human tumor vaccines.

Khazaie K, Bonertz A, Beckhove P.

Curr Opin Oncol. 2009 Nov;21(6):524-30. doi: 10.1097/CCO.0b013e328331a78e. Review.

PMID:
19770763
9.

Rational peptide-based tumour vaccine development and T cell monitoring.

Scheibenbogen C, Letsch A, Schmittel A, Asemissen AM, Thiel E, Keilholz U.

Semin Cancer Biol. 2003 Dec;13(6):423-9. Review.

PMID:
15001161
10.

WT1 peptide vaccine as a paradigm for "cancer antigen-derived peptide"-based immunotherapy for malignancies: successful induction of anti-cancer effect by vaccination with a single kind of WT1 peptide.

Oka Y, Tsuboi A, Fujiki F, Li Z, Nakajima H, Hosen N, Shirakata T, Nishida S, Oji Y, Kawase I, Sugiyama H.

Anticancer Agents Med Chem. 2009 Sep;9(7):787-97. Epub 2009 Sep 1. Review.

PMID:
19538172
11.
12.

[General principles and first clinical trials of therapeutic vaccines against cancer].

Baurain JF, Van der Bruggen P, Van den Eynde BJ, Coulie PG, Van Baren N.

Bull Cancer. 2008 Mar;95(3):327-35. doi: 10.1684/bdc.2008.0588. Review. French.

13.

Immune suppression in the tumor microenvironment.

Gajewski TF, Meng Y, Harlin H.

J Immunother. 2006 May-Jun;29(3):233-40. Review.

PMID:
16699366
14.

Immunogenic HER-2/neu peptides as tumor vaccines.

Baxevanis CN, Sotiriadou NN, Gritzapis AD, Sotiropoulou PA, Perez SA, Cacoullos NT, Papamichail M.

Cancer Immunol Immunother. 2006 Jan;55(1):85-95. Epub 2005 Oct 27. Review.

PMID:
15948002
15.

Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.

Nicholaou T, Ebert L, Davis ID, Robson N, Klein O, Maraskovsky E, Chen W, Cebon J.

Immunol Cell Biol. 2006 Jun;84(3):303-17. Review.

PMID:
16681828
16.

Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines.

Jinushi M, Hodi FS, Dranoff G.

Immunol Rev. 2008 Apr;222:287-98. doi: 10.1111/j.1600-065X.2008.00618.x. Review.

PMID:
18364009
17.

Tumor vaccine: current trends in antigen specific immunotherapy.

Baral R.

Indian J Exp Biol. 2005 May;43(5):389-406. Review.

PMID:
15900903
18.

Melanoma cancer vaccines and anti-tumor T cell responses.

Vujanovic L, Butterfield LH.

J Cell Biochem. 2007 Oct 1;102(2):301-10. Review.

PMID:
17647270
19.

Autologous, hapten-modified vaccine as a treatment for human cancers.

Berd D.

Vaccine. 2001 Mar 21;19(17-19):2565-70. Review.

PMID:
11257393
20.

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

Knutson KL, Disis ML.

Cancer Immunol Immunother. 2005 Aug;54(8):721-8. Epub 2005 Jan 27. Review.

PMID:
16010587

Supplemental Content

Support Center